---
title: "Merck & Company, Inc. Stock 12‑Month Price Target Raised to $157.72, Implies 8% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301629054.md"
description: "Merck & Company's average 12-month price target was raised to $157.72 by 25 analysts, up from $156.92, implying an 8% upside based on the Oct. 9 closing price. The consensus rating remains 'Buy' among 31 covering analysts, with 21 buys, 9 holds, and 1 sell."
datetime: "2026-10-12T22:20:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301629054.md)
  - [en](https://longbridge.com/en/news/301629054.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301629054.md)
generator: "portal-rs"
---

# Merck & Company, Inc. Stock 12‑Month Price Target Raised to $157.72, Implies 8% Upside

-   According to estimates from 25 analysts, Merck & Company, Inc. stock's average price target has risen from $156.92 to $157.72, with forecasts ranging from $105 to $186 per share
-   Based on the Oct. 9 closing price, the updated target implies approximately 8% potential upside
-   Consensus rating remains at “Buy” across 31 covering analysts, with 21 Buys, 9 Holds and 1 Sells

Explore more price target data and ratings for Merck & Company, Inc. on the , and track all previous and future analyst recommendations for Merck & Company, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [Braun Stacey Associates Inc. Has $35.07 Million Stock Position in Merck & Co., Inc. $MRK](https://longbridge.com/en/news/297397633.md)
- [What Is Merck (MRK) Betting On With Its $2.13 Billion KRAS Deal?](https://longbridge.com/en/news/300416193.md)
- [IREN Stock: Why Analysts Still See Over 200% Upside Despite This Week's Plunge](https://longbridge.com/en/news/302922686.md)
- [Why Did Analysts Slash Bloom Energy Stock (BE) Price Targets Despite Praising Q3 Earnings Beats?](https://longbridge.com/en/news/302920834.md)
- [Meta's Q3 FCF Turns Negative On AI Spend—Q4 Capex Implied At $49B-59B](https://longbridge.com/en/news/302907063.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**